SEC Form 4 · accession 0001140361-16-063466
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Pendarvis
Officer — Chief Administrative Officer
Period of report
May 3, 2016
Accepted (ET)
May 5, 2016 · 9:08 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | May 3, 2016 | M | 6,000 | $33.70 | A | 80,287 | D | |
| ResMed Common StockF3 | May 3, 2016 | S | 6,000 | $56.02 | D | 74,287 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $33.70 | May 3, 2016 | M | 6,000 | D | Nov 11, 2011 | Nov 11, 2017 | ResMed Common Stock | 6,000 | 36,033 | D |
Explanation of responses
- F1The transaction was conducted under a 10b5-1 Plan.
- F2Represents date options first became exercisable. Options vest 1/4 per year.
- F3This transaction was executed in multiple trades at prices ranging from $55.92 to $56.05. The price reported above reflects the weighted average sale price.